The panel analyzed how the proliferation of internet-connected communication devices, like...
The total number of deals in the global gene therapy market more than doubled from 16 in 2013 to...
The pushback against soaring cancer drug prices is gaining steam. A leading doctors group on...
While the Phase III portion of the pipeline is comparatively small, it is followed by a relatively large Phase II, indicating that there will be a sustained stream of products moving through the later development stages.
Researchers have found an easy way to produce carbon nanoparticles that are small enough to evade the body's immune system, reflect light in the near-infrared range for easy detection, and carry payloads of pharmaceutical drugs to targeted tissues.
Huntington’s disease attacks the part of the brain that controls movement, destroying nerves with a barrage of toxicity, yet leaves other parts relatively unscathed.
Rich, creamy, nutritious and now cancer fighting. New research reveals that molecules derived from avocados could be effective in treating a form of cancer.
Chemists have invented the first practical, scalable method for synthesizing jiadifenolide, a plant-derived molecule that may have powerful brain-protecting properties.
A MERS outbreak has infected about 150 people in South Korea, after a businessman apparently brought the virus back from the Middle East. Authorities are scrambling to control the spread of the illness, known fully as the Middle East Respiratory Syndrome. But a vaccine is not among their tools – since it doesn’t yet exist, and is probably not close to being developed.
Current drugs block the actions of only about a quarter of known disease-causing proteins, but researchers have developed a technology capable of not just inhibiting, but destroying every protein it targets.
According to a new study, women experiencing difficulty with time management, attention, organization, memory, and problem solving – often referred to as executive functions – related to menopause may find improvement with a drug already being used to treat attention deficit hyperactivity disorder (ADHD).
Greater awareness of inflammatory back pain will lead to an increase in diagnosed prevalent cases of Ankylosing Spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) across the 7MM by 2024.
Researchers have identified the molecular interactions that allow capsaicin to activate the body’s primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain.
A company in the Netherlands is working on a needle-free vaccine candidate for treating human respiratory syncytial virus (RSV).
The company's massive database of genetic information it collected over the years will play an important role in this new project.
Sticky plaque gets the most attention, but now healthy seniors at risk of Alzheimer's are letting scientists peek into their brains to see if another culprit is lurking.
The company expects that while vaccines will be an essential component of future dengue and malaria prevention and control efforts, immunization cannot succeed as a silver bullet solution for either disease.
Scientists have figured out all the steps to make morphine and similar painkillers without using opium poppies, opening the door for home-brewed drugs and even wider abuse.
The hope is that this standard can be used among the scientific community to see how well their genomic analysis tools match up.
Whether you’re brainy, brawny or both, you may someday benefit from a drug found to rejuvenate aging brain and muscle tissue.
These companies are having an interesting year so far.
Standard versions of this screening process would have only been able to pinpoint ovarian cancer in less than half of this group.
GlaxoSmithKline and the University of North Carolina Chapel Hill are teaming up to run this operation.
It has been hailed as the equivalent of Google Maps for the human body by The New York Times, and now the award-winning mobile-friendly platform BioDigital Human is looking to change the way healthcare information is shared, consumed and understood.
Researchers say a new epilepsy drug holds promise as a treatment for Alzheimer's disease.
Watson, the supercomputer seen on Jeopardy, will play an important role in this partnership.
Dying patients sometimes seek emergency access to experimental medicines, desperate for a last-chance treatment even if there's little proof it could help. Now drug giant Johnson & Johnson is taking an unusual step, turning to independent bioethicists for advice on when to say yes or no.
Disease-modifying treatments and novel symptomatic therapies with innovative mechanisms of action will enter the arena during the forecast period and become routinely used in care.
- Page 1